Munafa Stock Market Course + Intraday & FNO calls 
500124 NEWS why is Dr.reddy's price falling or rising
500124 NEWS reasons for why stock price of Dr.reddy's is falling or rising
500124 Dr Reddy is falling or rising technical reasons
Technical analysis forecast of Dr Reddy Stock is that its in a uptrend for shortterm, and I will avoid taking a SHORT or SELL trade in this stock. Look for opportunities to BUY or go LONG in Dr Reddy 500124 at this time. Stock is rising and might rise more.
It appears as if Dr Reddy 500124 gave a large move recently.
Stock of Dr Reddy (500124) is trading above an important moving average line, and it has been above this line for quite some time now. This is a good sign, and the stock might keep rising and move higher!
Although my analysis for Dr Reddy is bullish for shortterm, but stock is over bought and there are high chances of some profit booking tomorrow. You might want to sell the stock tomorrow in intra day with a stoploss of 1258.2, for a target of 1221.2 or 1190.37
500124 Dr Reddy is falling or rising NEWS fundamental reasons
Dr Reddys Laboratories Ltd up for third straight session Dr Reddys Laboratories Ltd is quoting at Rs 1243, up 1.8% on the day as on 12:49 IST on the NSE. The stock is up 1.58% in last one year as compared to a 7.89% slide in NIFTY and a 25.3% slide in the Nifty Pharma index. - NEWS as on 2026-09-29 business-standard.com
Market wrap: Infosys, Dr Reddy's Labs, Tata Motors PV, Power Grid top gainers and losers on Nifty and Sensex on Monday Indian equity markets ended sharply lower on Monday, with the Nifty falling 1.56% and the Sensex declining 1.52% as all sectoral indices closed in the red. PSU banks and realty stocks led the decline, while Dr Reddy’s Labs and Infosys were among the few ga - NEWS as on 2026-09-28 indiatimes.com
Dr Reddys Share Price Highlights: Dr. Reddys Stock Price History - NEWS as on 2026-09-21 indiatimes.com
QDENGA dengue vaccine to hit India market in 2027; Dr Reddy’s to sell it India's first approved dengue vaccine, QDENGA, will launch in the private market by mid-2027. Dr Reddy's Laboratories will distribute and promote the vaccine for individuals aged four to sixty. Takeda will retain rights for public market distribution as a - NEWS as on 2026-09-18 indiatimes.com
Dr Reddy's inks pact with Gilead for once-yearly HIV prevention drug lenacapavir Dr Reddy's Laboratories and Gilead Sciences have signed a licensing agreement. This pact involves investigational once-yearly lenacapavir for HIV prevention. The agreement facilitates manufacturing and supply planning for 120 countries. This collaborati - NEWS as on 2026-09-17 indiatimes.com
More announcements and NEWS
500124 Dr.reddy's current price & indicator signals
Recent prices of 500124 Dr.reddy's are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 29 Tue Sep 2026 | 1250.00 | 1229.35 to 1252.00 | 2.25% | 2.76 times |
| 28 Mon Sep 2026 | 1222.50 | 1204.15 to 1229.80 | 1.64% | 1.92 times |
| 25 Fri Sep 2026 | 1202.80 | 1194.90 to 1207.10 | 0.2% | 0.3 times |
| 24 Thu Sep 2026 | 1200.40 | 1196.85 to 1214.35 | -0.8% | 0.73 times |
| 23 Wed Sep 2026 | 1210.10 | 1205.10 to 1220.10 | -0.16% | 0.46 times |
| 22 Tue Sep 2026 | 1212.00 | 1201.05 to 1221.60 | 0.83% | 1.56 times |
| 21 Mon Sep 2026 | 1202.00 | 1186.20 to 1211.65 | 2.64% | 0.61 times |
| 18 Fri Sep 2026 | 1171.10 | 1171.10 to 1207.50 | -0.08% | 1.35 times |
| 17 Thu Sep 2026 | 1172.05 | 1140.50 to 1188.90 | 2.34% | 1.61 times |
| 16 Wed Sep 2026 | 1145.25 | 1134.00 to 1149.95 | -0.39% | 1.17 times |
| 15 Tue Sep 2026 | 1149.75 | 1140.00 to 1168.00 | -0.97% | 0.3 times |
| 11 Fri Sep 2026 | 1161.00 | 1131.05 to 1181.40 | 1.77% | 0.92 times |
Videos related to: 500124 NEWS why is Dr.reddy's price falling or rising
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
Hindi Basics How To Trade In FnO Futures Options Stock Market
- BSE Screeners
- BSE Daily Screener
- BSE Weekly Screener
- BSE Monthly Screener
- Support & Resistance
- BSE Shares Near Support
- BSE Shares Near Resistance
